molecular function |
| GO:0003779 | | actin binding | | Interacting selectively and non-covalently with monomeric or multimeric forms of actin, including actin filaments. |
| GO:0019899 | | enzyme binding | | Interacting selectively and non-covalently with any enzyme. |
| GO:0043522 | | leucine zipper domain binding | | Interacting selectively and non-covalently with a leucine zipper domain, a protein secondary structure exhibiting a periodic repetition of leucine residues at every seventh position over a distance covering eight helical turns. |
| GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| GO:0005080 | | protein kinase C binding | | Interacting selectively and non-covalently with protein kinase C. |
| GO:0008157 | | protein phosphatase 1 binding | | Interacting selectively and non-covalently with the enzyme protein phosphatase 1. |
| GO:0003714 | | transcription corepressor activity | | Interacting selectively and non-covalently with a repressing transcription factor and also with the basal transcription machinery in order to stop, prevent, or reduce the frequency, rate or extent of transcription. Cofactors generally do not bind the template nucleic acid, but rather mediate protein-protein interactions between repressive transcription factors and the basal transcription machinery. |
biological process |
| GO:0051017 | | actin filament bundle assembly | | The assembly of actin filament bundles; actin filaments are on the same axis but may be oriented with the same or opposite polarities and may be packed with different levels of tightness. |
| GO:0097202 | | activation of cysteine-type endopeptidase activity | | Any process that initiates the activity of the inactive enzyme cysteine-type endopeptidase. |
| GO:0006915 | | apoptotic process | | A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died. |
| GO:0097190 | | apoptotic signaling pathway | | A series of molecular signals which triggers the apoptotic death of a cell. The pathway starts with reception of a signal, and ends when the execution phase of apoptosis is triggered. |
| GO:0071392 | | cellular response to estradiol stimulus | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen. |
| GO:0071372 | | cellular response to follicle-stimulating hormone stimulus | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a follicle-stimulating hormone stimulus. |
| GO:0071347 | | cellular response to interleukin-1 | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-1 stimulus. |
| GO:0071306 | | cellular response to vitamin E | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin E stimulus. |
| GO:0050966 | | detection of mechanical stimulus involved in sensory perception of pain | | The series of events involved in the perception of pain in which a mechanical stimulus is received and converted into a molecular signal. |
| GO:0050965 | | detection of temperature stimulus involved in sensory perception of pain | | The series of events involved in the perception of pain in which a temperature stimulus is received and converted into a molecular signal. |
| GO:0042094 | | interleukin-2 biosynthetic process | | The chemical reactions and pathways resulting in the formation of interleukin-2. |
| GO:0030889 | | negative regulation of B cell proliferation | | Any process that stops, prevents or reduces the rate or extent of B cell proliferation. |
| GO:0042130 | | negative regulation of T cell proliferation | | Any process that stops, prevents or reduces the rate or extent of T cell proliferation. |
| GO:0050860 | | negative regulation of T cell receptor signaling pathway | | Any process that stops, prevents, or reduces the frequency, rate or extent of signaling pathways initiated by the cross-linking of an antigen receptor on a T cell. |
| GO:0090281 | | negative regulation of calcium ion import | | Any process that decreases the rate, frequency, or extent of the directed movement of calcium ions into a cell or organelle. |
| GO:0000122 | | negative regulation of transcription from RNA polymerase II promoter | | Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
| GO:0045760 | | positive regulation of action potential | | Any process that activates or increases the frequency, rate or extent of action potential creation, propagation or termination. This typically occurs via modulation of the activity or expression of voltage-gated ion channels. |
| GO:0042986 | | positive regulation of amyloid precursor protein biosynthetic process | | Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of amyloid precursor protein (APP), the precursor of amyloid-beta. |
| GO:0043065 | | positive regulation of apoptotic process | | Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process. |
| GO:0060450 | | positive regulation of hindgut contraction | | Any process that increases the frequency, rate or extent of muscle contraction of the hindgut, the posterior part of the alimentary canal, including the rectum, and the large intestine. |
| GO:1903238 | | positive regulation of leukocyte tethering or rolling | | Any process that activates or increases the frequency, rate or extent of leukocyte tethering or rolling. |
| GO:0043525 | | positive regulation of neuron apoptotic process | | Any process that activates or increases the frequency, rate or extent of cell death of neurons by apoptotic process. |
| GO:1904457 | | positive regulation of neuronal action potential | | Any process that activates or increases the frequency, rate or extent of neuronal action potential. |
| GO:2000391 | | positive regulation of neutrophil extravasation | | Any process that activates or increases the frequency, rate or extent of neutrophil extravasation. |
| GO:0032516 | | positive regulation of phosphoprotein phosphatase activity | | Any process that activates or increases the activity of a phosphoprotein phosphatase. |
| GO:1901082 | | positive regulation of relaxation of smooth muscle | | Any process that activates or increases the frequency, rate or extent of relaxation of smooth muscle. |
| GO:0006355 | | regulation of transcription, DNA-templated | | Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription. |
| GO:0032355 | | response to estradiol | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen. |
| GO:0010040 | | response to iron(II) ion | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an iron(II) ion stimulus. |
| GO:0032496 | | response to lipopolysaccharide | | Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria. |
| GO:0009611 | | response to wounding | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating damage to the organism. |
| GO:0006351 | | transcription, DNA-templated | | The cellular synthesis of RNA on a template of DNA. |
cellular component |
| GO:0015629 | | actin cytoskeleton | | The part of the cytoskeleton (the internal framework of a cell) composed of actin and associated proteins. Includes actin cytoskeleton-associated complexes. |
| GO:0005884 | | actin filament | | A filamentous structure formed of a two-stranded helical polymer of the protein actin and associated proteins. Actin filaments are a major component of the contractile apparatus of skeletal muscle and the microfilaments of the cytoskeleton of eukaryotic cells. The filaments, comprising polymerized globular actin molecules, appear as flexible structures with a diameter of 5-9 nm. They are organized into a variety of linear bundles, two-dimensional networks, and three dimensional gels. In the cytoskeleton they are most highly concentrated in the cortex of the cell just beneath the plasma membrane. |
| GO:0030424 | | axon | | The long process of a neuron that conducts nerve impulses, usually away from the cell body to the terminals and varicosities, which are sites of storage and release of neurotransmitter. |
| GO:0005737 | | cytoplasm | | All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| GO:0043005 | | neuron projection | | A prolongation or process extending from a nerve cell, e.g. an axon or dendrite. |
| GO:0043025 | | neuronal cell body | | The portion of a neuron that includes the nucleus, but excludes cell projections such as axons and dendrites. |
| GO:0005634 | | nucleus | | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
| GO:0005886 | | plasma membrane | | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |